Current Controversies in Gastroenterology & Hepatology

Saturday, February 9, 2013

Course Logistics

General Information Instructional Team
Registration Agenda

Registration

Non-UTSW Residents/Fellows $50
Physicians $375
UTSW Alumni $150
UTSW GI Faculty Complimentary

Course Directors

Tasneem Ahmed, D.O.
Assistant Professor, Department of Internal Medicine
UT Southwestern Medical Center
Amit Singal, M.D.
Assistant Professor, Department of Internal Medicine
UT Southwestern Medical Center

Guest Faculty

Martin Freeman, M.D.
Professor of Medicine
Interim Director
Division of Gastroenterology
University of Minnesota
Edward V. Loftus, Jr., M.D.
Professor of Medicine
Chair, Inflammatory Bowel Disease Interest Group
Division of Gastroenterology & Hepatology
Mayo Clinic
Rochester, Minn.

Location

Westin Galleria
Dallas, Texas

Who Should Attend/Target Audience

The course is designed for gastroenterologists, hepatologists, GI surgeons, internists, and family practice physicians, as well as physician assistants with an interest in gastroenterology and hepatology.

Purpose and Content

The purpose of this course is to provide an update in various current issues of hepatology, inflammatory bowel disease, hepatobiliary and pancreatic diseases, and colorectal cancer screening. The program includes didactic lectures, case presentations, and question and answer sessions with the course faculty.

Educational Objectives

Upon completion of this course, participants should be able to link the educational objectives to Core Competencies and be able to:

  • Describe new and current treatment guidelines for Hepatitis C (Medical Knowledge and Patient Care)
  • Review controversies in screening for Hepatocellular Carcinoma in Cirrhotic patients (Medical Knowledge, Patient Care, and Practice-Based Learning)
  • Describe the current treatment endpoints in Inflammatory Bowel Disease as well as the shift in goals of therapy to mucosal healing (Medical Knowledge and Practice-Based Learning)
  • Assess duration of treatment with immunomodulator and biologic therapy in Inflammatory Bowel Disease (Medical Knowledge and Practice-Based Learning)
  • Review the safety data on modulator and biologic therapy in Inflammatory Bowel Disease (Medical Knowledge and Practice-Based Learning)
  • Analyze the screening guidelines  for sessile serrated adenomas and right sided colon cancers (Medical Knowledge and Practice-Based Learning)
  • Discuss current endoscopic management of biliary strictures (Medical Knowledge, Patient Care, and Practice-Based Learning)
  • Discuss endoscopic sampling of pancreatic cysts (Medical Knowledge and Practice-Based Learning)
  • Illustrate the new biologic agents available for IBD, and to understand some of the more difficult clinical aspects of caring for the IBD patients (Medical Knowledge, Patient Care, and Practice-Based Learning)
  • Report on intestinal motility with emphasis on diagnosis and treatment options (Medical Knowledge, Patient Care, and Practice-Based Learning)

Sponsorship

Sponsored by UT Southwestern Department of Internal Medicine and the Office of Continuing Medical Education.
This live activity has been approved for AMA PRA Category 1 Credit TM.

Additional Information

Contact cmeregistrations@utsouthwestern.edu or 214-648-3138.